Drug intelligence / Profile preview

hypertonic short-peptide enteral nutrition suspension

Development stage
Unknown
Lead developer
Fresenius Kabi
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Oral, Enteral (tube Feeding)
01

Overview

Hypertonic short-peptide enteral nutrition suspension is a specialized medical nutrition product designed for patients with severe impairment of digestive and/or absorptive function, such as those with incomplete gastrointestinal structure or function. It contains hydrolyzed whey protein (mainly di- and tri-peptides), medium-chain triglycerides, carbohydrates, vitamins, minerals, and other nutrients in a hypertonic suspension form. The formulation allows for direct absorption by the small intestinal mucosa without requiring extensive digestion[2][5]. Its primary clinical use is to provide enteral nutritional support to patients who cannot tolerate whole protein formulas due to malabsorption or digestive dysfunction. The product can be administered orally or via feeding tube (enteral route). Hypertonic formulations have higher osmolality than isotonic products and may increase the risk of diarrhea or gastric retention in some patients[1][6]. This type of preparation is typically fiber-free and lactose-free.

Other names
高渗短肽肠内营养混悬液
02

Targets

PepT1/PepT2 (Peptide transporters 1/2)

Beyond the preview

Go deeper on hypertonic short-peptide enteral nutrition suspension.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hypertonic short-peptide enteral nutrition suspension.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call